1:IMRT

3 trials

Sponsors

Zhongnan Hospital of Wuhan University, Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Fudan University Shanghai Cancer Center

Conditions

NSCLCThyroid cancerbreast cancer

Phase 2

Intensity modulated radiation therapy combined with apatinib for inoperable or iodine refractory thyroid cancer, a phase II single-arm study

RecruitingChiCTR-OIN-17011812

Fudan University Shanghai Cancer CenterThyroid cancer

Start: 2017-07-01Updated: 2017-07-03

Unknown Phase

A study for local control and safety of intracranial lesions in patients with brain metastasis of breast cancer by whole-brain + local focal intensity modulated radiotherapy

RecruitingChiCTR1900024879

Zhongnan Hospital of Wuhan Universitybreast cancer

Start: 2019-08-01Updated: 2019-08-27

Boost lymphocyte activation following IMRT in patients with non-small-cell lung cancer: a retrospective study based on medical records

Active, not recruitingChiCTR1900027314

Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and TechnologyNSCLC

Start: 2019-12-01Updated: 2019-11-11